A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma

BACKGROUND: Approximately 50% of uveal melanoma (UM) patients develop metastases preferentially in the liver leading to death within 15 months. Currently, there is no effective treatment for metastatic UM, in part because the tumor burden is typically high when liver metastases are detected through...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jin, Merbs, Shannath L., Sokoll, Lori J., Chan, Daniel W., Zhang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399902/
https://www.ncbi.nlm.nih.gov/pubmed/30867659
http://dx.doi.org/10.1186/s12014-019-9230-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399902/
https://www.ncbi.nlm.nih.gov/pubmed/30867659
http://dx.doi.org/10.1186/s12014-019-9230-8

Ejemplares similares